⌘K

Login Start Free

Home/Filings/4/0001213900-21-050522

4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-21-050522

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 2:00 PM ET

Size

4.5 KB

Accession

0001213900-21-050522

Insider Transaction Report

Form 4

Period: 2021-09-28

InMed Pharmaceuticals Inc.INM

DirectorCEO & President10% Owner

Transactions

Purchase
Common Stock
2021-09-28$1.75/sh+11,400$19,984→ 27,483 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001817882

Filing Metadata

Form type: 4
Filed: Sep 28, 8:00 PM ET
Accepted: Sep 29, 2:00 PM ET
Size: 4.5 KB

View on SEC.gov